Astrana Health (ASTH) Cash & Current Investments (2010 - 2026)

Astrana Health has disclosed Cash & Current Investments across 17 years of filings, most recently posting $478.4 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $478.4 million, up 83.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $478.4 million (up 83.35% YoY), and the FY2025 annual result was $429.5 million, up 47.67% from the prior year.
• Cash & Current Investments came in at $478.4 million for Q1 2026 at Astrana Health, up from $429.5 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $478.4 million in Q1 2026 to a low of $217.3 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $296.3 million (2023), against an average of $323.3 million.
• Across the five-year window, Cash & Current Investments tumbled 34.81% in 2022 and surged 83.35% in 2026, its largest moves.
• Astrana Health's Cash & Current Investments stood at $293.6 million in 2022, then advanced by 0.92% to $296.3 million in 2023, then dropped by 1.85% to $290.8 million in 2024, then surged by 47.67% to $429.5 million in 2025, then gained by 11.39% to $478.4 million in 2026.
• The last three Cash & Current Investments figures came in at $478.4 million (Q1 2026), $429.5 million (Q4 2025), and $463.4 million (Q3 2025), per Business Quant data.